Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Sandoz Ltd, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, UK
Oxaliplatin 5 mg/ml Concentrate for Solution for Infusion.
Pharmaceutical Form |
---|
Concentrate for solution for infusion. Clear, colourless liquid. pH: 4.5 – 6.5 |
1 ml concentrate for solution for infusion contains 5 mg oxaliplatin.
10 ml of concentrate for solution for infusion contains 50 mg of oxaliplatin.
20 ml of concentrate for solution for infusion contains 100 mg of oxaliplatin.
30 ml of concentrate for solution for infusion contains 150 mg of oxaliplatin.
40 ml of concentrate for solution for infusion contains 200 mg of oxaliplatin.
50 ml of concentrate for solution for infusion contains 250 mg of oxaliplatin.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Oxaliplatin |
Oxaliplatin is an antineoplastic active substance belonging to a new class of platinum-based compounds in which the platinum atom is complexed with 1,2-diaminocyclohexane (“DACH”) and an oxalate group. |
List of Excipients |
---|
Water for injections |
Colourless glass vials with grey Halobutyl rubber stoppers and aluminium seals with plastic flip-off caps, with or without a protective plastic overwrap (Onco-Safe).
Pack sizes:
50mg/10ml: 1 vial, 5 vials, 10 vials
100mg/20ml: 1 vial
150mg/30ml: 1 vial
200mg/40ml: 1 vial
250mg/50ml: 1 vial
Not all pack sizes may be marketed.
Sandoz Ltd, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, UK
PL 04416/1604
17/12/2010
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.